United States · FDA National Drug Code directory
POTELIGEO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42747-761_2002b8eb-c6a6-4f3f-8a58-963fe6c015c4
- Product NDC
- 42747-761
- Form
- INJECTION
- Composition / generic term
- mogamulizumab-kpkc
- Labeler
- Kyowa Kirin, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180808
- Source listing expiry
- 20271231
Source-listed ingredients
- MOGAMULIZUMAB — 4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (42747-761-01) / 5 mL in 1 VIAL, GLASS · 42747-761-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →